Active Pharmaceutical Ingredientia
Progestogen et estrogen | |||
Product Name | Specificatio | Probatus | Cas No. |
Progesterone | CP / EP / USP / JP | CEP / EU-GMP / FDA | 57-83-0 |
Pregnenolone | In-domo |
Kosher | 145-13-1 |
Medroxyprogesterone ACETATE | CP / EP / USP / JP | Dmf / GMP | 71-58-9 |
MESTERROL acetate | CP / EP / USP | Dmf in processususus | 595-33-5 |
Mifepristone | CP / IP | Dmf / GMP | 84371-65-3 |
Cyproterone acetate | CP / EP / IP / KP | CEP / TGA / EU-GMP | 427-51-0 |
Levonorgestrel | CP / EP / USP / IP | CEP / GMP | 797-63-7 |
Norethisterone |
CP / EP / USP / JP |
Dmf in processususus |
68-22-4 |
Norethisterone acetate |
EP / USP |
Dmf in processususus |
51-98-9 |
Norethisterone Enanthate |
In-domo |
Sub R & D |
3836-23-5 |
Dripirenone | EP / USP | Dmf | 67392-87-4 |
Gestodene | CP / Album | Dmf / GMP | 60282-87-3 |
Estradiol | CP / EP / USP / KP | Dmf / GMP / WC | 35380-71-3 |
Estriol | CP / EP / USP | Sub R & D | 50-27- I |
Ethinyl estradiol | CP / EP / USP | Gmp | 57-63-6 |
Estradiol Valerate | CP / EP / USP / KP | Dmf | 979-32-8 |
Estradiol cypionate |
Usp | Dmf in processususus |
313-06-4 |
Tubolone | CP / Album | Dmf / GMP | 5630-53-5 |
Dienogest | Map | CEP / GMP | 65928-58-7 |
Fullevestrant | EP / USP | Sub R & D | 129453-61-8 |
Exemestane | CP / EP / USP | Sub R & D | 107868-30-4 |
Androgen | |||
Product Name | Specificatio | Probatus | Cas No. |
Finasteride | CP / EP / USP | CEP / FDA / PMDA / GMP | 98319-26-7 |
PRAESTITUTUM | EP / USP | CEP / FDA | 164656-23-9 |
Abiratone acetate | CP / USP | Dmf / WC | 154229-18-2 |
Darolutami |
In-domo |
Sub R & D |
1297538-32-9 |
Testosterone | CP / EP / USP | CEP / WC / FDA | 58-22-0 |
Testosterone undecanoate | CP | Dmf / WC | 5949-44-0 |
Testosterone cypionate | Usp | Sub R & D | 58-20-8 |
Testosterone enanthate |
USP / JP | Sub R & D |
315-37-7 |
Testosterone propionate |
CP / EP / USP / JP |
Sub R & D |
57-85-2 |
DHEA (in pracers) | FP /In-domo | Dmf / WC / Kosher | 53-43-0 |
Clascoterone | In-domo | Dmf in processususus | 19608-29-8 |
Cortical hormone | |||
Product Name | Specificatio | Probatus | Cas No. |
Budesonide | CP / EP / USP / JP | CEP / FDA / GMP | 51333-22-3 |
DESON | CP / USP | Dmf / GMP | 638-94-8 |
Eplerenone | Map | CEP in processusus | 107724-20-9 |
Methylprednisolone | CP / EP / USP / JP | Dmf / GMP | 83-43-2 |
Methylprednisolone Hemisuccinate | CP / EP / USP | Dmf / GMP | 2921-57-5 |
Fluticasone propionate | CP / EP / USP | Dmf | 80474- 14-2 |
Fluticasone ira | CP / Album | Dmf in processususus | 397864-44-7 |
Mometasone furoate |
CP / EP / USP |
Dmf in processususus |
Anhydrous (83919-23-7) Monohydrate (141646-00-6) |
Deflazacort |
In-domo |
Sub R & D |
14484-47-0 |
Alii | |||
Product Name | Specificatio | Probatus | Cas No. |
Oxcarbazepine | CP / EP / USP / IP | CEP / FDA / GMP | 28721-07-5 |
ESICARBAZEPAZIPAE ACETATE | CP / USP | Dmf | 236395- 14-5 |
Ganciclovir | CP / EP / USP | Dmf / GMP | 82410-32-0 |
VALCANCICLOVIR Hydrochloride | USP / Album | CEP in processus | 175865-59-5 |
Oseltamivir phosphate | CP / EP / USP | Dmf | 204255- 11-8 |
Baloxavir Marboxil | In-domo | Sub R & D | 1985606-14-1 |
Revefenacin | In-domo | Dmf | 864750-70-9 |
Mirabegron | CP / Album | Dmf | 223673-61-8 |
Vibegron |
In-domo |
Sub R & D |
1190389-15-1 |
Escitalopram oxalate | CP / EP / USP | Dmf in processusus | 219861-08-2 |
Citalopram hydrobromide |
CP / EP / USP |
Dmf in processususus |
59729-32-7 |
Cariprazine Hydrochloride | In-domo | Dmf | 1083076-69-0 |
LASMIDITAN | In-domo | Dmf | 439239-92-6 |
Luliconazole | In-domo | Dmf | 187164-19-8 |
Apalutami | In-domo | Dmf | 956104-40-8 |
Tadalafil | CP / EP / USP | Sub R & D | 171596-29-5 |
Relugolix | In-domo | Dmf in processusus | 737789-87-6 |
Phosphate Ruxolitinib |
In-domo |
Dmf in processususus |
1092939-17-7 |
Abemaciclib |
In-domo |
Sub R & D |
1231929-97-7 |
Phloroglucinol | CP / Album | Dmf | 108-73-6 |
1,3,5, trimethoxybenzene |
CP / in-Domus |
Gmp |
621-23-8 |
Ursodeoxycholic acidum | EP / USP / JP | Sub R & D | 128-13-2 |
Tauroursodeoloxycholic acidum |
In-domo |
Sub R & D |
14605-22-2 |
Cholesterol |
CP / EP / USP / JP |
Sub R & D |
57-88-5 |
Omega-III-acidum ethyl aether XC |
EP / USP |
Dmf in processususus |
- |
Medium-torquem triglycerides |
CP / USP / Album |
Dmf |
- |
Benzalkonium chloride |
USP / EP / JP |
CEP in processusus |
8001-54-5 |
Oleum (quia iniectio) |
CP / USP / EP / JP |
Dmf in processususus |
8001-25-0 |
Ovum phospholipids (quia iniectio) |
CP / USP / Album |
Dmf |
93685-90-6 |
Snack |
In-domo |
Dmf in processususus |
203787-91-1 |
Fluticasone furoate has in-domus specificationes. DMF fub interpositione.
Mometasone furoate speciem habet CPãEPãUSP. DMF fub interpositione.
Acetate Eslicarbazepine habet specificationem In-domus. DMF probatus.
Valganciclovir hydrochloride USP specificationem habet. DMF probatus.
Oseltamivir Phosphate CP, EP et USP specifications.DMF in promptu habet.
Revefenacin habet specificationem in domo. DMF probatus.